Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8<sup>+</sup> T-cell response and effective tumor control.
Where this comes from
- Record sourced from PubMed, PMID 32238807.
- Also identified by DOI 10.1038/s41467-020-15532-1 and PMC identifier 7113269.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.